These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31324454)

  • 1. Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study.
    Woelber L; Eulenburg C; Kosse J; Neuser P; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Ignatov A; Hillemanns P; Fürst S; Strauss HG; Mahner S; Prieske K;
    Gynecol Oncol; 2019 Sep; 154(3):571-576. PubMed ID: 31324454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.
    Woelber L; Griebel LF; Eulenburg C; Sehouli J; Jueckstock J; Hilpert F; de Gregorio N; Hasenburg A; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann KH; Thiel FC; Mustea A; Meier W; Harter P; Wimberger P; Hanker LC; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Neuser P; Mahner S
    Eur J Cancer; 2016 Dec; 69():180-188. PubMed ID: 27837710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should Groin Recurrence Still Be Considered as a Palliative Situation in Vulvar Cancer Patients?: A Brief Report.
    Frey JN; Hampl M; Mueller MD; Günthert AR
    Int J Gynecol Cancer; 2016 Mar; 26(3):575-9. PubMed ID: 26894938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of recurrence and survival in vulvar cancer: A nationwide population-based study.
    Zach D; Åvall-Lundqvist E; Falconer H; Hellman K; Johansson H; Flöter Rådestad A
    Gynecol Oncol; 2021 Jun; 161(3):748-754. PubMed ID: 33736857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral groin and pelvic irradiation for unilaterally node-positive women with vulval carcinoma.
    Jackson KS; Fankam EF; Das N; Naik R; Lopes AD; Godfrey KA; Hatem MH; Branson AN; Taylor WT
    Int J Gynecol Cancer; 2006; 16(1):283-7. PubMed ID: 16445646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of first recurrence and outcomes in surgically treated women with vulvar cancer: results from FRANCOGYN study group.
    Pirot F; Chaltiel D; Ouldamer L; Touboul C; Raimond E; Carcopino X; Daraï E; Bendifallah S
    J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101775. PubMed ID: 32438137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of removed lymph nodes by inguinofemoral lymphadenectomy: impact on recurrence rates in patients with vulva carcinoma.
    Diehl A; Volland R; Kirn V; Thangarajah F; Eichler C; Einzmann T; Wirtz M; Ratiu D; Morgenstern B; Fridrich C; Mallmann P; Puppe J
    Arch Gynecol Obstet; 2016 Jul; 294(1):131-6. PubMed ID: 26498758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer.
    van Beekhuizen HJ; Auzin M; van den Einden LC; de Hullu JA; van der Velden J; Wildhagen MF; van Doorn HC
    Int J Gynecol Cancer; 2014 May; 24(4):773-8. PubMed ID: 24662136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
    Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
    Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system?
    Thaker NG; Klopp AH; Jhingran A; Frumovitz M; Iyer RB; Eifel PJ
    Gynecol Oncol; 2015 Feb; 136(2):269-73. PubMed ID: 25524458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
    Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
    Fonseca-Moutinho JA; Coelho MC; Silva DP
    J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
    Te Grootenhuis NC; Pouwer AW; de Bock GH; Hollema H; Bulten J; van der Zee AGJ; de Hullu JA; Oonk MHM
    Gynecol Oncol; 2018 Mar; 148(3):622-631. PubMed ID: 29137809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.
    Mahner S; Jueckstock J; Hilpert F; Neuser P; Harter P; de Gregorio N; Hasenburg A; Sehouli J; Habermann A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Thiel F; Mustea A; Meier W; du Bois A; Griebel LF; Woelber L;
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
    Klapdor R; Hillemanns P; Wölber L; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Habermann A; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Meier W; Harter P; Wimberger P; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Jäger M; Mahner S
    Ann Surg Oncol; 2017 May; 24(5):1314-1321. PubMed ID: 27896515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system.
    Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA
    Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.
    Burger MP; Hollema H; Emanuels AG; Krans M; Pras E; Bouma J
    Gynecol Oncol; 1995 Jun; 57(3):327-34. PubMed ID: 7774836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
    Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 study.
    Woelber L; Prieske K; Eulenburg CZ; Corradini S; Petersen C; Bommert M; Blankenstein T; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann MW; Mustea A; Mahner S; Jaeger A
    Gynecol Oncol; 2022 Jan; 164(1):68-75. PubMed ID: 34794839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of recurrence of vulvar squamous cell carcinoma: analysis of 18 cases].
    Song YN; Yang JX; Shen K; Huang HF; Pan LY
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(19):1347-9. PubMed ID: 18956707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.